Medical-Grade or Consumer Wearable? How to Choose

Since the late 1980s, wearable devices have helped researchers collect data on the physical...

Using Wearables to Assess Fall Risk in Older Adults | DEAR Grant Profile

Falls can cause injuries and even deaths among adults age 65 and older, making falls a serious...

Advancing ALS Research with DHTs: Where Are We Now?

Amyotrophic Lateral Sclerosis (ALS) is a devastating, progressive neuromuscular disease that has...

Evaluating Usability and Incorporating the Patient Experience in DECODE-Nocturnal Scratch

The Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) Nocturnal Scratch...

Developing a Patient-Centric Measure of Nocturnal Scratch: A Q&A with DiMe

The adoption of wearable Digital Health Technologies (DHTs) to measure outcomes of interest in...

Perspective on the FDA's Final Digital Health Technologies Guidance

Regulatory guidance plays a pivotal role in shaping the ecosystem of clinical research and...

ActiTrack Adherence Monitoring: Maximize the Value of Wearable Data

In the evolving landscape of clinical trials, wearable digital health technologies give clinical...

Frequently Asked Questions: ActiGraph LEAP

The ActiGraph LEAP™next generation multisensor wearable device is now available for use in academic...

Researching New Digital Measures in Heart Disease | DEAR Grant Profile

Cardiovascular diseases, according to the World Health Organization, are the leading cause of death...

The Vital Role of Clinical Research Sites in DHT Deployment

Once your team has made the decision to collect digital measures in your clinical trial and...

Frequently Asked Questions: ActiGraph GT9X Link

As Ametris discontinues the sale of new ActiGraph GT9X Link wearable digital health technology...

Ametris Selling the final inventory of ActiGraph GT9X Link wearables devices and transitioning into end-of-life support

On August 23, 2023, Ametris (formerly ActiGraph) formally announced the sunsetting of GT9X Link...